SATT Ouest Valorisation (investor - Others)
See something wrong or missing? Let us know
Offices:Rennes
Average round investment:4.78M USD
Average number per year:1.0
Distribution:
2023 (1)2022 (1)2020 (1)
Portfolio companies:
SurfactGreen
BioMAdvanced Diagnostics
SurfactGreen
BioMAdvanced Diagnostics
Mostly invests in:
France (3)
Biotech (3)
France (3)
Biotech (3)
3 tracked investments in:
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Investors with similar profile to SATT Ouest Valorisation
| Name | Criteria | |
|---|---|---|
![]() |
BFC Angels
83%
|
|
![]() |
Newton Biocapital
83%
|
|
![]() |
Coalescence
83%
|
|
![]() |
Beast Ventures
83%
|
|
![]() |
Techno'start
83%
|
|
![]() |
Créazur
83%
|
|
![]() |
Agoranov
83%
|
|
![]() |
Christian Dahlen
83%
|
|
![]() |
Alsace Business Angels
83%
|
|
![]() |
Caméléon Invest
83%
|
|



Netherlands
Austria
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
Ireland
Italy
Portugal
Spain